网站综合信息 www.bjcancer.com
- 标题:
- British Journal of Cancer
- 关键字:
- nature nature publishing group BJC British Journal Cancer cancer r
- 描述:
- 域名信息
- 域名年龄:26年7个月17天 注册日期:1999年06月30日 到期时间:2015年06月30日
邮箱:admin 电话:+1.8887802723
注册商:CSC CORPORATE DOMAINS, INC.
- 服务器空间
- IP:199.168.13.77 同IP网站2个 详情
地址:美国
- 备案信息
- 备案号:
域名流量Alexa排名
域名注册Whois信息
bjcancer.com
域名年龄: 26年7个月17天注册时间: 1999-06-30
到期时间: 2015-06-30
注 册 商: CSC CORPORATE DOMAINS, INC.
注册邮箱: admin
联系电话: +1.8887802723
获取时间: 2015年01月23日 08:58:03
Domain Name: BJCANCER.COM
Registrar: CSC CORPORATE DOMAINS, INC.
Sponsoring Registrar IANA ID: 299
Whois Server: whois.corporatedomains.com
Referral URL: http://www.cscglobal.com/digitalbrandservices
Name Server: NS0-B.DNS.PIPEX.NET
Name Server: NS1-B.DNS.PIPEX.NET
Status: clientTransferProhibited
Updated Date: 2013-06-27
Creation Date: 1999-06-30
Expiration Date: 2015-06-30
>>> Last update of whois database: Fri, 2015-Jan-23 01:00:29 GMT <<<
For more information on Whois status codes, please visit
https://www.icann.org/resources/pages/epp-status-codes-2014-06-16-en.
Domain Name: bjcancer.com
Registry Domain ID: 7608376_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.corporatedomains.com
Registrar URL: www.cscprotectsbrands.com
Updated Date: 2013-12-10 21:20:02 -0500
Creation Date: 1999-06-30 00:00:00 -0400
Registrar Registration Expiration Date: 2015-06-30 09:03:36 -0400
Registrar: CSC CORPORATE DOMAINS, INC.
Registrar IANA ID: 299
Registrar Abuse Contact Email: admin
Registrar Abuse Contact Phone: +1.8887802723
Domain Status: clientTransferProhibited
Registry Registrant ID:
Registrant Name: Adam Horwitz
Registrant Organization: Nature America
Registrant Street: 75 Varick Street
Registrant City: New York
Registrant State/Province: NY
Registrant Postal Code: 10013
Registrant Country: US
Registrant Phone: +1.2127269226
Registrant Phone Ext:
Registrant Fax: +1.6465637040
Registrant Fax Ext:
Registrant Email: A.Horwitz
Registry Admin ID:
Admin Name: Glenn Tunaley
Admin Organization: Nature Publishing Group
Admin Street: 75 Varick Street
Admin City: New York
Admin State/Province: NT
Admin Postal Code: 10013
Admin Country: US
Admin Phone: +1.2127269348
Admin Phone Ext:
Admin Fax: +1.2126969006
Admin Fax Ext:
Admin Email: g.tunaley
Registry Tech ID:
Tech Name: Adam Horwitz
Tech Organization: Nature America
Tech Street: 75 Varick Street
Tech City: New York
Tech State/Province: NY
Tech Postal Code: 10013
Tech Country: US
Tech Phone: +1.2127269226
Tech Phone Ext:
Tech Fax: +1.6465637040
Tech Fax Ext:
Tech Email: A.Horwitz
Name Server: ns1-b.dns.pipex.net
Name Server: ns0-b.dns.pipex.net
DNSSEC:
URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net/
>>> Last update of WHOIS database: 2013-12-10 21:20:02 -0500 <<<
Corporation Service Company(c) (CSC) The Trusted Partner of More than 50% of the 100 Best Global Brands.
Contact us to learn more about our enterprise solutions for Global Domain Name Registration and Management, Trademark Research and Watching, Brand, Logo and Auction Monitoring, as well SSL Certificate Services and DNS Hosting.
NOTICE: You are not authorized to access or query our WHOIS database through the use of high-volume, automated, electronic processes or for the purpose or purposes of using the data in any manner that violates these terms of use. The Data in the CSC WHOIS database is provided by CSC for information purposes only, and to assist persons in obtaining information about or related to a domain name registration record. CSC does not guarantee its accuracy. By submitting a WHOIS query, you agree to abide by the following
Register your domain name at http://www.cscglobal.com
For more information on Whois status codes, please visit https://www.icann.org/resources/pages/epp-status-codes-2014-06-16-en
网站头文件(HTTP Header)
HTTP/1.0 302 Found 目标网址:http://www.nature.com/bjc/index.html 服务器:BigIP 连接:Keep-Alive 文件大小:0 HTTP/1.1 200 OK 服务器:Jetty(6.1.26) 过期时间:1970年01月01日 08:00:00-Jan-1970 00:00:00 GMT webserver: npgj2ee6.nature.com 类型:text/html; charset=utf-8 隐私:CP="CAO DSP LAW IVA IVD HIS OUR UNR STP UNI COM" 动作:Accept-Encoding Content-Encoding: gzip 访问时间:2016年10月23日 14:16:45 文件大小:13330 连接:keep-alive 设置Cookie:SaneID=10.1.1.222.1477203404178216; path=/; domain=.nature.com 设置Cookie:JSESSIONID=h0a1tj9pcptgqk4xprtz3dgu;Path=/ 设置Cookie:login_encoded=null;Path=/;Expires=Thu, 01-Jan-1970 00:00:00 GMT 设置Cookie:JSESSIONID=h0a1tj9pcptgqk4xprtz3dgu;Path=/oa;Domain=.nature.com 设置Cookie:lang=zh;Expires=Mon, 23-Oct-2017 06:16:44 GMT 网站编码:utf-8 页面编码:iso-8859-1
同IP网站(同服务器)
其他后缀域名
网站首页快照(纯文字版)
抓取时间:2016年10月23日 14:12:36
网址:http://www.bjcancer.com/
标题:British Journal of Cancer
关键字:nature, nature publishing group, BJC, British Journal Cancer, cancer research, cancers, prescription drugs, breast cance
描述:
主体:
网址:http://www.bjcancer.com/
标题:British Journal of Cancer
关键字:nature, nature publishing group, BJC, British Journal Cancer, cancer research, cancers, prescription drugs, breast cance
描述:
主体:
We use cookies to improve your experience with our site.Accept and close | More info.Jump to main contentJump to navigationnature.com homepagePublications A-Z indexBrowse by subjectMy accountSubmit manuscriptRegisterSubscribeLoginCartSearchAdvanced searchWelcome to BJCMultidisciplinary Journal of Cancer ResearchBJC publishes significant original papers and reviews that:increase understanding of the causes of cancerinform timely detection and accurate diagnosisinvestigate molecular pathways relevant to cancer therapycontribute to the discovery of novel therapieshelp develop personalised therapydrive improvements in the treatment and survival of patientsBJC is one of the most-cited general cancer journalsVol 115, No 8(October 2016)ISSN 0007-09202015 Impact Factor 5.569*28/213 Oncology*2015 Journal Citation Reports® Science Edition (Thomson Reuters, 2016)SupplementsPARP inhibitors in ovarian cancerGuest editors: Jonathan A LedermannVol 113, No S1 (December 2015) Comprehensively reviews molecular and clinical evidence underlying the evolution of poly (ADP-ribose) polymerase (PARP) inhibitors culminating in the recent licensing approval of the first oral PARP inhibitor, for BRCA-mutated high-grade serous ovarian cancer.Organized by AstraZeneca UKWeb FocusThe changing landscape of breast cancer prognostic predictionWe increasingly recognize that multiple factors influence disease outcome in breast cancer. A series of papers in the BJC shed new lights on how the method of diagnosis (screen detected versus self-detected), timing of initiation of therapy, factors that influence treatment compliance, and molecular features of the cancer contribute to treatment outcome. Understanding these variables that influence survival is critical for making optimal treatment recommendations in the clinic and also defines areas for future research.New drugs to watchThere are over 500 new anti-cancer drugs in various stages of clinical development. The BJC remains an important venue to report clinical trial results. The following is a brief selection of recently published trials with promising new drugs to watch.Melanoma: the great leap forwardMetastatic melanoma has been among the most difficult cancers to treat with limited and highly toxic treatment options. Recent advances in immune checkpoint inhibitors and molecularly targeted drugs have profoundly changed the life expectancy and quality of life of patients with metastatic melanoma. Therapeutic options are broadening for these patients and these recent articles in the BJC illustrate the trajectory of current research.Systemic Inflammation as a Prognostic MarkerSystemic signs of inflammation are emerging as valuable biomarkers for prognosis and treatment stratification. This WebFocus features papers showing how simple indicators based on neutrophilia and lymphocytopenia can provide prognostic information in many cancer types and promise significant clinical value.Click to view:Web Focus on Clinical significance
最近查询网站